Figure 2From: Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy Intra-treatment comparison between final and basal values for heart iron and function in patients with basal global heart T2* value < 20 ms. Back to article page